ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.726,76
-0,21%
S&P 500
5.321,41
0,25%
Dow Jones
39.872,99
0,17%
Euro vs US Dollar
1,08575
-0,03%
Bitcoin
69.617,80
-2,56%
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Rhythm Pharmaceuticals Inc (RYTM)

  7. Rhythm Pharmaceuticals Inc (RYTM) News

RYTM

Rhythm Pharmaceuticals (RYTM)

Rhythm Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:RYTM
DatumZeitQuelleÜberschriftSymbolFirma
13/05/202422h21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
09/05/202422h17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
09/05/202422h01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
07/05/202422h43Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RYTMRhythm Pharmaceuticals Inc
07/05/202413h10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYTMRhythm Pharmaceuticals Inc
07/05/202413h00GlobeNewswire Inc.Rhythm Pharmaceuticals Reports First Quarter 2024 Financial Results and Business UpdateNASDAQ:RYTMRhythm Pharmaceuticals Inc
06/05/202414h00GlobeNewswire Inc.Rhythm Pharmaceuticals Presents Data from Phase 3 Pediatrics Trial at Pediatric Endocrine Society Annual MeetingNASDAQ:RYTMRhythm Pharmaceuticals Inc
30/04/202400h30GlobeNewswire Inc.Rhythm Pharmaceuticals Announces Publication of Results from Phase 2 Study of Setmelanotide for the Treatment of Hypothalamic Obesity in The Lancet Diabetes & EndocrinologyNASDAQ:RYTMRhythm Pharmaceuticals Inc
24/04/202422h01GlobeNewswire Inc.Rhythm Pharmaceuticals to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024NASDAQ:RYTMRhythm Pharmaceuticals Inc
16/04/202422h01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
01/04/202414h00GlobeNewswire Inc.Rhythm Pharmaceuticals Secures $150 Million in Convertible Preferred Stock FinancingNASDAQ:RYTMRhythm Pharmaceuticals Inc
25/03/202413h00GlobeNewswire Inc.Rhythm Pharmaceuticals Announces First Patient Dosed in Phase 1 Trial Evaluating RM-718, a Weekly MC4R-specific AgonistNASDAQ:RYTMRhythm Pharmaceuticals Inc
11/03/202421h01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces New Employment Inducement GrantsNASDAQ:RYTMRhythm Pharmaceuticals Inc
06/03/202422h01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces Participation at Upcoming Investor ConferencesNASDAQ:RYTMRhythm Pharmaceuticals Inc
29/02/202422h58Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:RYTMRhythm Pharmaceuticals Inc
29/02/202422h46Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYTMRhythm Pharmaceuticals Inc
29/02/202422h44Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:RYTMRhythm Pharmaceuticals Inc
29/02/202422h05Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:RYTMRhythm Pharmaceuticals Inc
22/02/202413h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RYTMRhythm Pharmaceuticals Inc
22/02/202413h01GlobeNewswire Inc.Rhythm Pharmaceuticals Announces Clinical Development Plan of Setmelanotide for Hypothalamic Obesity in JapanNASDAQ:RYTMRhythm Pharmaceuticals Inc
22/02/202413h00GlobeNewswire Inc.Rhythm Pharmaceuticals Reports Fourth Quarter 2023 Financial Results and Business UpdateNASDAQ:RYTMRhythm Pharmaceuticals Inc
22/02/202401h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
22/02/202401h01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
22/02/202401h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
22/02/202401h00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
16/02/202400h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
14/02/202402h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
14/02/202402h47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
14/02/202402h46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
14/02/202402h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RYTMRhythm Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:RYTM

Kürzlich von Ihnen besucht

TG
LHA
Deutsche Lufthansa
TG
BAS
BASF
TG
NOV
Novo Nordisk
NASDAQ
TSLA
Tesla
FX
EURUSD
Euro vs US Dollar
COIN
ETHUSD
Ethereum
NYSE
KO
Coca Cola
NYSE
DIS
Walt Disney
CCOM
US100
US Tech 100
TG
DTE
Deutsche Telekom
NYSE
XOM
Exxon Mobil
TG
D7G
Nel ASA
DBI
MDAX
MDAX
AMEX
SPY
SPDR S&P 500
AMEX
XLE
Energy Select Sector SPDR
DBI
SDXP
SDAX
Delayed Upgrade Clock
ADVFN Logo

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten